Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.
Mestag Therapeutics has raised $40.0M in total funding. The most recent round was Series Unknown. The last funding was announced in March 2026.
Mestag Therapeutics's investors include Forbion Capital Partners, SV Health Investors, Google Ventures, Innovate UK, Johnson & Johnson Innovation.
Mestag Therapeutics is headquartered in Cambridge, United Kingdom.
Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.
Mestag Therapeutics is at the Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mestag Therapeutics — Funding & Investors." VCBacked, March 17, 2026, https://www.vcbacked.co/company/mestag-therapeutics. Accessed September 30, 2026.
VCBacked. (2026). Mestag Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/mestag-therapeutics
{{cite web |title=Mestag Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mestag-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated